Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Indianapolis Tribune.
Press releases published on May 22, 2025

Valbruna Slater Stainless to Invest $28 Million in Fort Wayne Plant Expansion
FORT WAYNE, IN, UNITED STATES, May 22, 2025 /EINPresswire.com/ -- Valbruna Slater Stainless, Inc. (VSSI), a subsidiary of Acciaierie Valbruna of Italy, announced it will invest approximatively $28 Million in expanding its stainless steel and nickel …

Bierman Autism Centers Unveils Clinical Research & Innovation Lab—Transforming Therapy into Field-Shaping Science
New lab turns routine ABA sessions and VR pilots into publishable research, offering fellowships and early access slots for clinicians. INDIANAPOLIS, IN, UNITED STATES, May 22, 2025 /EINPresswire.com/ -- Bierman Autism Centers (BAC) announces the launch …

THOR Industries Announces Date for its Fiscal 2025 Third Quarter Earnings Release
ELKHART, Ind., May 22, 2025 (GLOBE NEWSWIRE) -- THOR Industries, Inc. (NYSE: THO) today announced that the date for its fiscal 2025 third quarter earnings release will be on Wednesday, June 4, 2025, before the market opens. Upon the release of THOR's …

First Capital, Inc. Announces Quarterly Dividend
CORYDON, Ind., May 22, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of First Capital, Inc. (NASDAQ: FCAP) has declared a quarterly cash dividend of $0.29 (twenty-nine cents) per share of common stock, according to Michael C. Frederick, President and …

Inotiv, Inc. to Present at Jefferies Global Healthcare Conference 2025
WEST LAFAYETTE, Ind., May 22, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models …

NeurAxis Announces Closing of $5.0 Million Registered Direct Offering
CARMEL, Ind., May 22, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults …